1. Home
  2. Analysis
  3. Wellbutrin-sr
  4. Fingolimod

Wellbutrin sr and Fingolimod drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Wellbutrin sr and Fingolimod together.

The phase IV clinical study analyzes what interactions people who take Wellbutrin sr and Fingolimod have. It is created by eHealthMe based on reports of 4 people who take the same drugs from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 04, 2022

4 people who take Wellbutrin sr and Fingolimod together, and have interactions are studied.

What is Wellbutrin sr?

Wellbutrin sr has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 11,312 Wellbutrin sr users for its effectiveness, alternative drugs and more.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 2,850 Fingolimod users for its effectiveness, alternative drugs and more.

Number of Wellbutrin sr and Fingolimod reports submitted per year:

Wellbutrin sr and Fingolimod drug interactions.

Common Wellbutrin Sr and Fingolimod drug interactions by gender *:

female:

  1. Back pain
  2. Groin pain
  3. Pain in extremity
  4. Asthenia
  5. Blood cholesterol increased
  6. Body mass index increased
  7. Dizziness
  8. Fatigue
  9. Lymphocyte count decreased
  10. Visual impairment

male:

  1. Alanine aminotransferase increased
  2. Areflexia
  3. Aspartate aminotransferase increased
  4. Blood glucose increased
  5. Confusional state
  6. Decreased appetite
  7. Dizziness
  8. Migraine
  9. Pruritus
  10. Weight decreased

Common Wellbutrin Sr and Fingolimod drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Groin pain
  3. Pain in extremity
  4. Blood cholesterol increased
  5. Body mass index increased
  6. Lymphocyte count decreased
  7. Weight increased

50-59:

  1. Dizziness
  2. Migraine
  3. Pruritus
  4. Weight decreased
  5. Alanine aminotransferase increased
  6. Areflexia
  7. Aspartate aminotransferase increased
  8. Blood glucose increased
  9. Confusional state
  10. Decreased appetite

60+:

  1. Asthenia
  2. Dizziness
  3. Fatigue
  4. Visual impairment

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin sr and Fingolimod?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Wellbutrin sr and Fingolimod:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Wellbutrin sr interactions:

Browse all interactions between Wellbutrin sr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fingolimod interactions:

Browse all interactions between Fingolimod and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride and fingolimod (the active ingredients of Wellbutrin sr and Fingolimod, respectively), and Wellbutrin sr and Fingolimod (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2022 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.